IL130052A0 - Method of treating glaucoma and ischemic retinopathy - Google Patents

Method of treating glaucoma and ischemic retinopathy

Info

Publication number
IL130052A0
IL130052A0 IL13005299A IL13005299A IL130052A0 IL 130052 A0 IL130052 A0 IL 130052A0 IL 13005299 A IL13005299 A IL 13005299A IL 13005299 A IL13005299 A IL 13005299A IL 130052 A0 IL130052 A0 IL 130052A0
Authority
IL
Israel
Prior art keywords
treating glaucoma
ischemic retinopathy
mammal
retinopathy
ischemic
Prior art date
Application number
IL13005299A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL130052A0 publication Critical patent/IL130052A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Eye Examination Apparatus (AREA)
  • Surgical Instruments (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
IL13005299A 1998-05-26 1999-05-19 Method of treating glaucoma and ischemic retinopathy IL130052A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8674598P 1998-05-26 1998-05-26

Publications (1)

Publication Number Publication Date
IL130052A0 true IL130052A0 (en) 2000-02-29

Family

ID=22200630

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13005299A IL130052A0 (en) 1998-05-26 1999-05-19 Method of treating glaucoma and ischemic retinopathy

Country Status (16)

Country Link
EP (1) EP0985414B1 (de)
JP (1) JP2000026297A (de)
KR (2) KR100469188B1 (de)
AT (1) ATE247963T1 (de)
AU (1) AU762037B2 (de)
CA (1) CA2272665C (de)
DE (1) DE69910706T2 (de)
DK (1) DK0985414T3 (de)
ES (1) ES2204067T3 (de)
HU (1) HUP9901728A3 (de)
IL (1) IL130052A0 (de)
MY (1) MY133222A (de)
NZ (2) NZ335952A (de)
PT (1) PT985414E (de)
TW (1) TW581678B (de)
ZA (1) ZA993528B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL358481A1 (en) * 2000-03-17 2004-08-09 Alcon Inc. 6-hydroxy-indazole derivatives for treating glaucoma
US6956036B1 (en) 2000-03-17 2005-10-18 Alcon, Inc. 6-hydroxy-indazole derivatives for treating glaucoma
AU2001258690A1 (en) * 2000-06-02 2001-12-11 Pfizer Products Inc. S-methyl-dihydro-ziprasidone for treatment of psychiatric and ocular disorders
US7504395B2 (en) 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2021262A1 (de) * 1970-04-30 1971-11-11 Cassella Farbwerke Mainkur Ag Piperazinderivate
US4130646A (en) * 1975-07-25 1978-12-19 E. R. Squibb & Sons, Inc. 1,2,3,4-Tetrahydro-2-((4-(phenyl)-1-piperazinyl)methyl)-1-naphthalenols and derivatives and analogs thereof
IE50867B1 (en) * 1980-02-29 1986-08-06 Kefalas As Indane derivatives
EP0233728A1 (de) * 1986-02-11 1987-08-26 Takeda Chemical Industries, Ltd. 1,4-Benzoxazin-Derivate, ihre Herstellung und Verwendung
US4831031A (en) * 1988-01-22 1989-05-16 Pfizer Inc. Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity
US5350747A (en) * 1989-07-07 1994-09-27 Pfizer Inc Heteroaryl piperazine antipsychotic agents
ZA9010081B (en) * 1989-12-20 1991-10-30 Merrell Dow Pharma Method for the treatment of glaucoma
CA2036307C (en) * 1990-03-08 2002-07-09 Susan Jean Ward 3-arylcarbonyl-1-aminoalkyl-1h-indole-containing antiglaucoma compositions and method
IL126590A (en) * 1996-05-07 2001-11-25 Pfizer Trihydrate salt of -5 (-2 (-4 (1 (2, 2-benzothiazole - 3yl) -1-piperazinyl) ethyl) - 6-chloro-1, 3-dihydro-2 (1H) - indole - 2On (= Ziprasidone) and pharmaceutical preparations containing it

Also Published As

Publication number Publication date
DE69910706D1 (de) 2003-10-02
JP2000026297A (ja) 2000-01-25
NZ335952A (en) 2001-01-26
ES2204067T3 (es) 2004-04-16
MY133222A (en) 2007-10-31
ZA993528B (en) 2000-11-27
NZ508246A (en) 2004-12-24
HUP9901728A3 (en) 2001-01-29
CA2272665A1 (en) 1999-11-26
AU3124299A (en) 1999-12-02
DE69910706T2 (de) 2004-07-08
DK0985414T3 (da) 2003-12-29
ATE247963T1 (de) 2003-09-15
CA2272665C (en) 2003-08-05
EP0985414B1 (de) 2003-08-27
EP0985414A2 (de) 2000-03-15
KR100469188B1 (ko) 2005-01-31
KR20030086544A (ko) 2003-11-10
AU762037B2 (en) 2003-06-19
KR19990088520A (ko) 1999-12-27
EP0985414A3 (de) 2000-04-05
HUP9901728A2 (hu) 2000-12-28
PT985414E (pt) 2004-01-30
TW581678B (en) 2004-04-01

Similar Documents

Publication Publication Date Title
HU9600834D0 (en) Quinazoline derivatives
NO176566C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive aminosyrederivater
PT928788E (pt) Compostos farmaceuticamente activos
CA2196995A1 (en) Spiro-azabicyclic compounds useful in therapy
EP0423714A3 (en) Hair revitalizing agent
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
PT992509E (pt) Novos derivados macrolidos
WO1999004770A3 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
ZA993528B (en) A compound for use in treating glaucoma and ischemic retinopathy.
TR200102009T2 (tr) Serebral işlemi profilaksı ve tedavisi için formül I'e göre bileşiklerin kullanımı
CA2190952A1 (en) Use of a naphthalenesulfonic acid compound for inhibiting retroviral infection
WO1996021670A3 (en) Antifungal fusacandins
US6541495B1 (en) Carboxylic acid derivatives as inhibitors of hyperproliferation diseases
WO2002056869A3 (en) Method for treating sexual disorders
MXPA99003849A (es) Derivados 9a, 11b-deshidro de 9-oxima-3-ceto-6-0-metileritromicina.
WO2002056870A3 (en) Method for treating sleep disorders
EP0452809A3 (en) A therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives
WO2002057286A3 (en) 9-amino erythromycin derivatives with antibacterial activity
EP0447812A3 (en) Use of a dihydropyridine to improve the inner ear blood circulation
WO2002056868A3 (en) Method for treating stress or tension
PH30180A (en) Leustroducsin h its preparation and its therapeutic use
AU6689194A (en) Dopamine reincorporation inhibitor